Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 86951-87000 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05985525
Microvascular Monitoring in Circulatory Shock and Sepsis (MiMICSS)
N/ARecruiting
100 participants
Started: May 27, 2022 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT04988516
Virtual Reality Distraction for Anxiety (VR-IMAGINE)
NARecruiting
98 participants
Started: May 27, 2022 · Completed: May 30, 2025
4 conditions2 sponsors1 location
NCT05265689
Study to Improve Adolescent Bicycling Safety
NARecruiting
195 participants
Started: May 27, 2022 · Completed: Dec 30, 2025
9 conditions2 sponsors1 location
NCT05601596
Research OutSmarts Endometriosis II Study
N/AEnrolling by invitation
185 participants
Started: May 27, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT05319808
Rehabilitation for Whiplash Associated Disorders
NAActive, not recruiting
180 participants
Started: May 27, 2022 · Completed: Apr 30, 2024
1 condition4 sponsors4 locations
NCT05300477
Pharmacological Countermeasures for High Altitude
PHASE4Active, not recruiting
18 participants
Started: May 27, 2022 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT04960384
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations
PHASE2Enrolling by invitation
50 participants
Started: May 27, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05909878
Virtual Reality Distraction for Anxiety (VR-IMAGINE at HSJ)
NARecruiting
98 participants
Started: May 27, 2022 · Completed: Jun 30, 2025
4 conditions1 sponsor1 location
NCT05174767
PERSEVERE- a Trial to Evaluate AMDS in Acute DeBakey Type I Dissection
NAActive, not recruiting
115 participants
Started: May 27, 2022 · Completed: Dec 6, 2029
1 condition2 sponsors25 locations
NCT05199194
Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke
PHASE3Recruiting
398 participants
Started: May 27, 2022 · Completed: Jul 31, 2027
2 conditions4 sponsors13 locations
NCT05168163
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
PHASE2Recruiting
122 participants
Started: May 27, 2022 · Completed: Dec 31, 2026
9 conditions3 sponsors16 locations
NCT05290246
TRE in Type 2 Diabetes (See Food Study 3)
NARecruiting
60 participants
Started: May 27, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05451303
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
N/ARecruiting
475 participants
Started: May 27, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05452291
Multiomics Biomarkers for Urolithiasis
N/ARecruiting
1,200 participants
Started: May 27, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05389293
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
PHASE2Recruiting
152 participants
Started: May 27, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor9 locations
NCT05297890
A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer
PHASE2Active, not recruiting
70 participants
Started: May 27, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors31 locations
NCT05281744
Collaborative Care Coordination Program for Alzheimer's Disease and Related Dementias
NAActive, not recruiting
2,160 participants
Started: May 27, 2022 · Completed: Mar 1, 2026
1 condition3 sponsors1 location
NCT05270525
Effect of Ensifentrine on Sputum Markers of Inflammation in COPD
PHASE2Recruiting
50 participants
Started: May 27, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors2 locations
NCT04890938
Sputum-guided Treatment With Comprehensive Care Management in COPD - A Randomized-controlled Trial
NARecruiting
128 participants
Started: May 27, 2022 · Completed: Aug 31, 2025
1 condition4 sponsors2 locations
NCT05041127
Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma
PHASE2Recruiting
15 participants
Started: May 27, 2022 · Completed: Sep 1, 2026
3 conditions1 sponsor1 location
NCT05879068
A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC
PHASE2Active, not recruiting
99 participants
Started: May 27, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor11 locations
NCT05300724
An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration
N/AActive, not recruiting
400 participants
Started: May 27, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor75 locations
NCT05338541
Tucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood.
PHASE1Recruiting
30 participants
Started: May 27, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05619822
A Comprehensive Third-generation Intervention for People With Psychosis and Post-traumatic Stress Symptoms
NAEnrolling by invitation
100 participants
Started: May 27, 2022 · Completed: Jul 30, 2026
2 conditions1 sponsor1 location
NCT04538573
Virtual Reality MObility for Burn Patients
NARecruiting
20 participants
Started: May 27, 2022 · Completed: May 30, 2024
1 condition1 sponsor1 location
NCT05780359
Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery
NARecruiting
280 participants
Started: May 27, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT05034432
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
PHASE4Recruiting
100 participants
Started: May 27, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors19 locations
NCT05008159
A Community-based Program That Supports Physical Activity, Healthy Eating, Social Participation and System Navigation in Older Adults
NARecruiting
500 participants
Started: May 27, 2022 · Completed: Mar 31, 2025
4 conditions4 sponsors2 locations
NCT06418087
Durvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma (LCNEC)
PHASE2Recruiting
49 participants
Started: May 27, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor15 locations
NCT04637594
Trying to Find the Correct Length of Treatment with Immune Checkpoint Therapy
PHASE3Active, not recruiting
3 participants
Started: May 27, 2022 · Completed: Sep 30, 2030
10 conditions2 sponsors377 locations
NCT05251714
CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer
PHASE1/PHASE2Active, not recruiting
44 participants
Started: May 27, 2022 · Completed: Aug 31, 2026
2 conditions1 sponsor4 locations
NCT05448625
Genoss DES in Patients With a High Risk of Ischemic Events (GENTLE Registry)
N/ARecruiting
200 participants
Started: May 26, 2022 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT05056597
Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa
N/ARecruiting
252 participants
Started: May 26, 2022 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT05139498
Conservative Management for PAS Pilot
NARecruiting
32 participants
Started: May 26, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05405582
"Thetha Nami Ngithethe Nawe (Let's Talk): Step Wedge cRCT of Peer Led Community PrEP and SRH for Youth in South Africa"
NARecruiting
6,000 participants
Started: May 26, 2022 · Completed: May 1, 2025
2 conditions1 sponsor1 location
NCT05486013
Zanubrutinib in the Treatment of Recurrent Refractory Mantle Cell Lymphoma
N/ARecruiting
30 participants
Started: May 26, 2022 · Completed: Nov 26, 2025
1 condition6 sponsors1 location
NCT05297552
A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer
PHASE2Recruiting
40 participants
Started: May 26, 2022 · Completed: Feb 28, 2025
1 condition1 sponsor3 locations
NCT05345444
Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)
NAActive, not recruiting
48 participants
Started: May 26, 2022 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT05170412
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
N/ARecruiting
80 participants
Started: May 26, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT06237400
A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.
PHASE1/PHASE2Recruiting
110 participants
Started: May 26, 2022 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT05317689
Comparing the Effects of Psilocin and Psilocybin in Healthy Adults
PHASE1Active, not recruiting
20 participants
Started: May 26, 2022 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT05298124
Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
NARecruiting
144 participants
Started: May 26, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor4 locations
NCT05147792
The CONFORM Pivotal Trial
NARecruiting
1,600 participants
Started: May 26, 2022 · Completed: Dec 31, 2031
2 conditions1 sponsor70 locations
NCT05262439
Post Market Clinical Follow Up of ResMed Mask Systems
NARecruiting
500 participants
Started: May 26, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05487612
MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
NARecruiting
1,300 participants
Started: May 26, 2022 · Completed: Mar 31, 2027
3 conditions2 sponsors12 locations
NCT05138250
A Pilot Study of the Use of 129Xe and 1H MRI to Measure the Modulation of Eosinophil-Related Inflammation by Mepolizumab In COPD
PHASE3Active, not recruiting
32 participants
Started: May 26, 2022 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT05366868
Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus
PHASE4Recruiting
567 participants
Started: May 26, 2022 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT05449067
Comparison of Efficacy Between Nighttime and Daytime Peritoneal Dialysis
NARecruiting
124 participants
Started: May 26, 2022 · Completed: Dec 30, 2025
2 conditions15 sponsors1 location
NCT05421689
Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia
PHASE1/PHASE2Active, not recruiting
66 participants
Started: May 26, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors2 locations
NCT05441722
CIPN in Early Stage Breast Cancer Patients
NAActive, not recruiting
48 participants
Started: May 26, 2022 · Completed: Jul 1, 2024
2 conditions4 sponsors1 location